Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 94
Filter
1.
Ophthalmic Plast Reconstr Surg ; 39(4): e115-e117, 2023.
Article in English | MEDLINE | ID: mdl-36893059

ABSTRACT

A 66-year-old immunocompromised man presented with cellulitis around the left eye that was initially concerning for necrotizing fasciitis. Exam findings were remarkable for exquisite periocular tenderness with rigid, immobile eyelids resulting from severe erythema, edema, and induration. Given the concern for orbital compartment syndrome and a necrotizing infection, the patient was taken urgently to the operating room for debridement of the eyelid skin as well as an urgent lateral canthotomy and cantholysis. His eye exam revealed 360° of hemorrhagic chemosis, no relative afferent pupillary defect, and an ipsilateral elevated intraocular pressure of 35 mm Hg. No visual acuity measurement could be obtained secondary to the patient's altered mental status. His intraocular pressure normalized after treatment with antihypertensive drops and further extension of the canthotomy. Histopathological analysis showed extensive neutrophilic infiltrate of the dermis which was compatible with a diagnosis of Sweet's syndrome.


Subject(s)
Intraocular Pressure , Sweet Syndrome , Male , Humans , Aged , Sweet Syndrome/diagnosis , Sweet Syndrome/complications , Sweet Syndrome/pathology , Orbit/pathology , Cellulitis/complications , Eyelids/pathology
2.
J Am Acad Dermatol ; 86(5): 1002-1009, 2022 05.
Article in English | MEDLINE | ID: mdl-33878406

ABSTRACT

BACKGROUND: Psychocutaneous disorders are often attributed to stimulant medications, yet this relationship has never been fully elucidated. Literature on psychocutaneous disorders largely focuses on clinical presentation and treatment rather than disease etiology or exacerbation. OBJECTIVE: To determine whether patients presenting with psychocutaneous disorders display high rates of stimulant use and psychiatric comorbidity. METHODS: We undertook a retrospective cohort study of patients with psychocutaneous disorders presenting to a single center. It was hypothesized that these patients would have high rates of stimulant use and psychiatric comorbidity. Following analysis of baseline demographics, the patients were assigned to 1 of 2 groups: those with a psychotic disorder and those with a neurotic disorder. RESULTS: Sixty percent of the patients (n = 317) with psychocutaneous disease had recently used a stimulant and more than 80% (270 of 317) carried an additional psychiatric diagnosis. The neurotic disorder group (n = 237) was younger and had higher rates of stimulant use. The psychotic disorder group (n = 80) had higher rates of psychosis, medical comorbidity, and illicit stimulant drug use. LIMITATIONS: The predominantly Caucasian population may limit generalizability of findings as may the retrospective nature. CONCLUSIONS: Patients with psychocutaneous disease have high rates of stimulant use and most have at least 1 psychiatric comorbidity.


Subject(s)
Central Nervous System Stimulants , Substance-Related Disorders , Central Nervous System Stimulants/adverse effects , Comorbidity , Humans , Retrospective Studies , Substance-Related Disorders/epidemiology
3.
J Cutan Pathol ; 49(12): 1025-1030, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35751643

ABSTRACT

Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMCT) is a recently described entity with only 13 cases reported in the literature. Histopathologically, the neoplasm consists of atypical epithelioid to spindled cells that form a well-circumscribed nodule usually confined to the dermis and subcutis with cytological features including large vesicular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Immunohistochemistry shows variable expressivity of melanocytic markers. Currently, there are limited data regarding long-term outcomes of this newly described entity. Most cases have done well, but there is one case reported with an adverse event. Hence, further studies are needed to accurately classify this tumor. Definitive diagnosis is made by laboratory evidence of CMCT. Herein, we report the first case of CMCT with epidermal involvement in the youngest patient known to be affected to date.


Subject(s)
Skin Neoplasms , Humans , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Gene Fusion , Transcription Factors/genetics , Melanocytes/pathology , Biomarkers, Tumor , Tripartite Motif Proteins/genetics , Ubiquitin-Protein Ligases/genetics
4.
Am J Dermatopathol ; 44(11): 822-827, 2022 Nov 01.
Article in English | MEDLINE | ID: mdl-35503883

ABSTRACT

BACKGROUND: Dermatofibromas are common skin tumors that typically occur on the extremities and trunk and demonstrate benign behavior, frequent recurrences, and very rare metastasis. Facial dermatofibromas are rare and not well studied . We analyzed clinicopathologic features of facial dermatofibromas. DESIGN: Considering the rarity of the condition, we conducted a cohort study and a systematic review. We queried medical records of a single tertiary care center for dermatofibromas from January 1, 2000, to July 1, 2021. A systematic review of multiple databases was conducted through October 27, 2021, to include studies reporting facial dermatofibromas. Random-effects meta-analysis was used to estimate pooled odds ratio and proportions with associated 95% confidence interval (CI). RESULTS: The cohort study identified 2858 cases of dermatofibromas, of which, 23 cases from 18 patients were on the face (1%). The mean age was 52.7 ± 17.8 years. Fifty-six percent of the cases were women. The most common location was the forehead (6 cases). The mean follow-up was 54 months. Forty-four percent of the cases had subcutaneous involvement, and 39% were the cellular type. Margins were positive in 89% of the cases, recurrence rate was 22%, and no metastases were observed. The systematic review included 10 studies (119 patients). Meta-analyses showed that facial dermatofibromas were 2% of all dermatofibromas (95% CI: 1%-3%). The local recurrence rate was 14% (95% CI: 6%-26%). Facial dermatofibromas with subcutaneous involvement were more likely to recur [odds ratio 4.53 (95% CI: 1.12-18.24)]. Before histopathologic examination, clinical differential diagnosis included dermatofibromas in only 9% of the cases (95% CI: 2%-19%). CONCLUSION: Facial dermatofibromas are rare and are difficult to fully excise. Cellular type and subcutaneous or muscular involvement are common in these cases and tend to have higher local recurrence rate than other nonfacial dermatofibromas. Wider excisions might be necessary for complete excision.


Subject(s)
Histiocytoma, Benign Fibrous , Skin Neoplasms , Adult , Aged , Cohort Studies , Diagnosis, Differential , Female , Forehead/pathology , Histiocytoma, Benign Fibrous/pathology , Humans , Male , Middle Aged , Skin Neoplasms/pathology
5.
J Cutan Pathol ; 48(10): 1303-1306, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34086358

ABSTRACT

Skeletal muscle regeneration (SMR) encompasses a sequence of events that unfolds after injury to muscle fibers. Nearby satellite cells become activated and function as precursor muscle cells by proliferating and differentiating into myoblasts, which eventually fuse to form myotubes and ultimately mature muscle fibers. Compared to other forms of mesenchymal repair, SMR has higher morphologic heterogeneity with the potential to show histopathologic similarities to sarcomas and other malignancies. It is important to recognize SMR and settings in which this can occur to avoid misdiagnosis. We report two cases where a diagnosis of SMR was made from tissue taken from locations previously treated with Mohs micrographic surgery followed by myofascial flap reconstruction. In both cases, histopathologic features identified with hematoxylin and eosin as well as immunostaining were used to support the diagnosis of SMR. These cases highlight the importance of recognizing this clinic entity to ensure accurate diagnosis.


Subject(s)
Muscle, Skeletal/physiology , Plastic Surgery Procedures/methods , Regeneration , Sarcoma/pathology , Wound Healing , Diagnosis, Differential , Humans , Male , Middle Aged , Mohs Surgery , Sarcoma/diagnosis , Skin Neoplasms/surgery , Surgical Flaps
6.
J Am Acad Dermatol ; 80(1): 189-207.e11, 2019 Jan.
Article in English | MEDLINE | ID: mdl-29689323

ABSTRACT

BACKGROUND: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy, and physician decision-making. OBJECTIVES: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. METHODS: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience, and expert judgment, was used to develop AUC in dermatopathology. RESULTS: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered "usually appropriate" and 52 (25%) "rarely appropriate" and 43 (20%) having "uncertain appropriateness." LIMITATIONS: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. CONCLUSIONS: The ultimate decision to order specific tests rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness-the AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed "uncertain appropriateness" and where consensus was not reached may benefit from further research.


Subject(s)
Medical Overuse/prevention & control , Skin Diseases/pathology , Dermatology/standards , Humans , Pathology, Clinical/standards
7.
J Cutan Pathol ; 46(9): 684-687, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31074019

ABSTRACT

Multiple cutaneous side effects have been reported with the use of immunotherapies including programmed cell death protein 1 inhibitors. We report 2 patients who presented with papillary dermal elastolysis presenting as multiple, skin-colored, wrinkled papules and atrophic macules following an inflammatory eruption in the setting of combination chemotherapy with nivolumab and cabiralizumab. These two cases highlight a novel finding, elastolysis in the setting of chemotherapy with nivolumab and cabiralizumab.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Drug Eruptions , Skin Pigmentation/drug effects , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Bone Neoplasms/drug therapy , Bone Neoplasms/metabolism , Bone Neoplasms/pathology , Dermis/metabolism , Dermis/pathology , Drug Eruptions/metabolism , Drug Eruptions/pathology , Female , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Middle Aged , Neoplasm Metastasis , Nivolumab/administration & dosage , Nivolumab/adverse effects , Osteosarcoma/drug therapy , Osteosarcoma/metabolism , Osteosarcoma/pathology
8.
J Cutan Pathol ; 45(1): 39-47, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29084365

ABSTRACT

BACKGROUND: Appropriate use criteria have been developed for many tests using expert judgment, evidence-based practice and clinical experience. In this context, we report the opinions of practitioners about clonality assays in various clinical scenarios where cutaneous lymphoma is suspected. METHODS: An Appropriate Use Criteria Task Force sponsored by the American Society of Dermatopathology (ASDP) synthesized clinical scenarios for cutaneous lymphoproliferative disorders (LPDs). We conducted, summarized and presented a relevant literature search to an audience of 144 dermatopathologists with a variety of practice experiences at the 53rd Annual Meeting of the ASDP in Chicago, IL. RESULTS: Twenty-seven clinical scenarios for LPDs (13 T-cell and 14 B-cell) were defined. Forty relevant studies for T-cell receptor gene clonality assays and 20 relevant studies for IgH/IgK clonality assays were identified. Audience response data from participating dermatopathologists reflected a wide variety of approaches to the application of clonality assays in the evaluation of LPDs, based on practice setting, personal experience and test availability. CONCLUSIONS: Our clinical scenario analysis and literature review revealed well-supported clinical scenarios and identified opportunities for additional research to further define the utility of clonality assays in some clinical scenarios.


Subject(s)
Dermatology , Lymphoma, B-Cell/diagnosis , Lymphoma, T-Cell/diagnosis , Pathology , Skin Neoplasms/diagnosis , Clone Cells , Humans , Practice Patterns, Physicians'
9.
J Cutan Pathol ; 45(8): 563-580, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29566273

ABSTRACT

BACKGROUND: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision-making. OBJECTIVES: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. METHODS: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology. RESULTS: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered "usually appropriate," 52 (25%) "rarely appropriate" and 43 (20%) "uncertain appropriateness." LIMITATIONS: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. CONCLUSIONS: The ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness-AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed "uncertain appropriateness" and where consensus was not reached may benefit from further research.


Subject(s)
Dermatology , Evidence-Based Medicine , Pathology , Diagnostic Tests, Routine , Humans , United States
10.
Can J Urol ; 25(3): 9328-9333, 2018 06.
Article in English | MEDLINE | ID: mdl-29900821

ABSTRACT

INTRODUCTION: Given the poor understanding of the pathophysiology of genital lichen sclerosus (GLS) and a lack of accepted definitive diagnostic criteria, we proposed to survey pathologists regarding their understanding of GLS. We hypothesized that significant disagreement about GLS will exist. MATERIALS AND METHODS: All urologists participating in the Trauma and Urologic Reconstruction Network of Surgeons identified genitourinary (GUP) and dermatopathologists (DP) at their respective institutions who were then invited to participate in an online survey regarding their experience with diagnosing GLS, GLS pathophysiology and its relationship to urethral stricture disease. RESULTS: There were 23 (12 DP, 11 GUP) pathologists that completed the survey. The most agreed upon criteria for diagnosis were dermal collagen homogenization (85.7%), loss of the normal rete pattern (33.3%) and atrophic epidermis (28.5%). No pathologists believed GLS had an infectious etiology (19% maybe, 42% unknown) and 19% believed GLS to be an autoimmune disorder (42% maybe, 38% unknown); 19% believed LS to be premalignant, but 52% believed it was associated with cancer; 80% believed that LS could involve the urethra (DP (92%) versus GUP (67%); p = 0.272). Of those diagnosing urethral GLS, 80% of DUP believed that GLS must first involve the glans/prepuce before involving the urethra, while all GUP believed that urethral disease could exist in isolation (p = 0.007). CONCLUSIONS: There was significant disagreement in this specialized cohort of pathologists when diagnosing GLS. A logical first step appears to be improving agreement on how to best describe and classify the disease. This may lead to improve treatments.


Subject(s)
Lichen Sclerosus et Atrophicus/pathology , Male Urogenital Diseases/pathology , Male Urogenital Diseases/surgery , Surveys and Questionnaires , Urethral Stricture/etiology , Urologic Surgical Procedures, Male/methods , Attitude of Health Personnel , Biopsy, Needle , Clinical Competence , Genitalia, Male/pathology , Health Care Surveys , Humans , Immunohistochemistry , Lichen Sclerosus et Atrophicus/surgery , Male , Male Urogenital Diseases/diagnosis , Pathologists/standards , Pathologists/trends , Practice Patterns, Physicians' , Retrospective Studies , Severity of Illness Index , United States , Urethral Stricture/pathology , Urethral Stricture/surgery
11.
J Cutan Pathol ; 44(4): 360-366, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28009441

ABSTRACT

Lymphomatoid papulosis (LyP), characterized by recurring, waxing and waning, cutaneous papulonodules, is increasingly recognized to represent a heterogeneous collection of pathologically dissimilar subtypes. Recently, a follicular LyP variant was proposed, featuring folliculotropism. Folliculotropism by atypical lymphocytes is conventionally associated with follicular mucinosis and mycosis fungoides (MF), and review of the literature suggests co-occurrence of folliculotropism and follicular mucinosis in LyP to be rare, with only 3 cases identified to date. Herein we describe 3 additional cases, each manifesting a typical LyP clinical picture, with the additional element of folliculotropism and follicular mucinosis on pathology. These cases suggest that LyP should be considered alongside MF in the differential diagnosis of follicular mucinosis with accompanying atypical lymphocytic infiltration. As LyP can occur with other lymphoproliferative disorders such as MF, the finding of follicular mucinosis in LyP may further represent a conceptual intersection between the 2 disease processes.


Subject(s)
Lymphomatoid Papulosis , Mucinosis, Follicular , Skin Neoplasms , Adult , Aged , Female , Humans , Lymphomatoid Papulosis/metabolism , Lymphomatoid Papulosis/pathology , Mucinosis, Follicular/metabolism , Mucinosis, Follicular/pathology , Skin Neoplasms/metabolism , Skin Neoplasms/pathology
13.
J Cutan Pathol ; 43(8): 684-7, 2016 Aug.
Article in English | MEDLINE | ID: mdl-26968987

ABSTRACT

Adenoid cystic carcinoma (ACC) is a tumor that can be of primary cutaneous origin or secondary to metastatic disease, most commonly salivary origin. Aside from primary cutaneous and salivary types, ACC of the breast is a rare, more indolent variant. Cutaneous metastases secondary to breast ACC is exceedingly uncommon and not previously reported to our knowledge. We present the case of a 67-year-old woman who developed cutaneous metastasis from primary breast ACC.


Subject(s)
Breast Neoplasms/pathology , Carcinoma, Adenoid Cystic/secondary , Head and Neck Neoplasms/secondary , Scalp/pathology , Skin Neoplasms/secondary , Aged , Female , Humans
15.
J Cutan Pathol ; 42(1): 16-21, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25404144

ABSTRACT

BACKGROUND: Evolving lesions of lichen sclerosus (LS) pose a diagnostic challenge owing to an absence of classic findings of epidermal atrophy, dermal sclerosis, a band-like lymphocytic infiltrate and the presence of eosinophils. METHODS: Retrospective specimens of LS were reviewed. Demographic information, biopsy vs. excision and the following histopathological characteristics were noted: presence and number of eosinophils, epidermal hyperplasia, spongiosis, early/transitional LS, well-developed LS and coexisting squamous cell carcinoma (SCC). Linear regression analysis was performed. RESULTS: The data consisted of 66 biopsies (36 male [M], 30 female [F]), from 53 individuals (33M, 20F), including 57 genital and 9 extragenital biopsies. Seven biopsies showed SCC, 28 showed epidermal hyperplasia and 14 exhibited spongiosis. Thirty-five specimens were early/transitional LS and commonly exhibited epidermal hyperplasia (57%), epidermotropism of lymphocytes (97%) and basement membrane thickening (97%). Thirty-five biopsies (53%) contained eosinophils (23 early/transitional lesions). Male gender (p = 0.074) was associated with increased eosinophils. The presence of SCC (p = 0.014) was a significant predictors of eosinophil number. CONCLUSIONS: Epidermal hyperplasia, epidermotropism of lymphocytes and basement membrane thickening are helpful features in identifying early LS. Eosinophils are not an uncommon finding in LS and are most common in male genital lesions and in LS associated with SCC.


Subject(s)
Eosinophils/pathology , Lichen Sclerosus et Atrophicus/pathology , Adult , Aged , Aged, 80 and over , Biopsy , Female , Humans , Male , Middle Aged , Retrospective Studies , Young Adult
16.
J Cutan Pathol ; 42(9): 645-51, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25761672

ABSTRACT

Herein, we describe a 63-year-old male with multiple tumors arising within a nevus sebaceus on the posterior scalp. On histopathologic examination, four distinct tumors were identified: trichoblastoma, syringocystadenoma papilliferum, desmoplastic trichilemmoma and tumor of the follicular infundibulum (TFI). Within the TFI component of the nevus sebaceus, there was intracytoplasmic accumulation of eosinophilic keratin, as shown on pancytokeratin-stained sections, imparting a signet-ring appearance to the cells. To our knowledge, this is the first report of signet-ring cells arising within a TFI occurring in a nevus sebaceus. We discuss this case as well as review the literature on multiple tumors arising within nevus sebaceus and signet-ring cell changes in primary cutaneous tumors.


Subject(s)
Carcinoma, Signet Ring Cell/pathology , Neoplasms, Multiple Primary/pathology , Nevus, Sebaceous of Jadassohn/pathology , Scalp/pathology , Skin Neoplasms/pathology , Sweat Gland Neoplasms/pathology , Cystadenoma/pathology , Diagnosis, Differential , Humans , Male , Middle Aged , Neoplasms, Adnexal and Skin Appendage/pathology
17.
Pediatr Dermatol ; 32(1): 148-50, 2015.
Article in English | MEDLINE | ID: mdl-25441121

ABSTRACT

We report a case of ulcerated atypical Spitz nevi that demonstrated a yellow to light orange background under dermoscopy, which can be seen in juvenile xanthogranuloma (JXG) and is referred to as the "setting sun" appearance. This yellow to orange appearance was due to serous crusting and not histiocytic infiltration, which is seen in JXG. This case highlights overlapping dermatoscopic features between the two skin lesions and polymorphous vascular structures, which are unique to atypical Spitz nevi.


Subject(s)
Nevus, Epithelioid and Spindle Cell/diagnosis , Skin Neoplasms/diagnosis , Xanthogranuloma, Juvenile/diagnosis , Dermoscopy , Diagnosis, Differential , Female , Humans , Infant
18.
J Cutan Pathol ; 41(4): 370-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24447075

ABSTRACT

A 62-year-old male presented with a 10-day history of a diffuse, erythematous papular rash sparing the palms and soles. Histopathologic examination of a skin lesion showed loose non-caseating granulomas in a lymphoplasmacytic background. Scattered spirochetes were identified by Treponema pallidum immunohistochemistry, in keeping with a diagnosis of secondary syphilis. Granulomatous inflammation in secondary syphilis is uncommon. A review of the literature reveals that the majority of prior reported cases of granulomatous secondary syphilis share similar characteristics to this case; namely, a papular or nodular clinical presentation, sparing of the palms and soles, and collections of epithelioid histiocytes with associated lymphocytes and variable numbers of plasma cells.


Subject(s)
Skin/pathology , Syphilis, Cutaneous/pathology , Syphilis/pathology , Treponema pallidum , Humans , Inflammation/microbiology , Inflammation/pathology , Male , Middle Aged , Skin/microbiology , Syphilis/microbiology , Syphilis, Cutaneous/microbiology
19.
Am J Dermatopathol ; 36(3): 264-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23739245

ABSTRACT

: Histiocytoid Sweet syndrome is a histopathologic variant of Sweet syndrome characterized by an infiltrate of mononuclear cells that have a histiocytic appearance and represent immature granulocytes. The primary histopathologic differential diagnosis for histiocytoid Sweet syndrome includes leukemia cutis and true histiocytic dermatoses. However, it does not usually include a deep mycotic infection. Herein, we describe a case of histiocytoid Sweet syndrome in a 75-year-old man in which histopathologic examination showed a dense dermal infiltrate composed of mature neutrophils and numerous yeast-like mononuclear cells with a surrounding halo, suspicious for cryptococcal organisms. Immunohistochemical and histochemical studies demonstrated expression of myeloperoxidase by the yeast-like forms and an absence of periodic acid-Schiff and mucicarmine staining. Microbiologic culture studies were negative for fungal organisms. The case met all the criteria for Sweet syndrome and, given the cytomorphology of the mononuclear cells with vesicular irregularly rounded nuclei and myeloperoxidase expression, the case was most consistent with histiocytoid Sweet syndrome. The perinuclear haloes in this case most likely represent cytoplasmic vacuolization of the immature, histiocytoid appearing neutrophils secondary to a novel nonapoptotic caspase-independent death pathway. This case highlights the histopathologic similarities that may be present between cryptococcal infection and histiocytoid Sweet syndrome, and the utility of immunohistochemical markers and histochemical staining to differentiate between the two entities.


Subject(s)
Cryptococcosis/pathology , Diagnosis, Differential , Myeloid Cells/pathology , Sweet Syndrome/pathology , Aged , Biomarkers/analysis , Humans , Immunohistochemistry , Male
20.
J Low Genit Tract Dis ; 18(3): e80-3, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24402357

ABSTRACT

OBJECTIVE: Vulvar ulcers may be caused by various etiologies including infection, trauma, dermatosis, and cancer. We report a case of a vulvar ulcer caused by botryomycosis. CASE: An 85-year-old woman presented with vulvar itching, pain, bleeding, and ulcerations suspicious for cancer. Biopsies of the ulcers returned without dysplasia or malignancy. She was referred to the tertiary care vulvar vaginal disease clinic. Dermatopathologic reevaluation of pathologic slides diagnosed lichen sclerosus and botryomycosis. The patient was treated with ciprofloxacin for 7 weeks with complete resolution of vulvar ulcerations. CONCLUSION: Botryomycosis should be included in the differential diagnosis of infectious etiology of vulvar ulcers.


Subject(s)
Botrytis/isolation & purification , Mycoses/diagnosis , Mycoses/pathology , Ulcer/etiology , Ulcer/pathology , Vulvar Diseases/diagnosis , Vulvar Diseases/pathology , Aged, 80 and over , Female , Humans , Mycoses/microbiology , Ulcer/microbiology , Vulvar Diseases/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL